Literature DB >> 7538627

Oculofacial-skeletal myorhythmia in central nervous system Whipple's disease: additional case and review of the literature.

D A Simpson1, R Wishnow, R B Gargulinski, A M Pawlak.   

Abstract

A case of oculofacial-skeletal myorhythmia associated with cerebral Whipple's disease is presented. This peculiar abnormal movement disorder consists of a convergent-divergent pendular nystagmus associated with a synchronous, rhythmic movement of the mouth, jaw, and extremities. The movements in previous cases have responded inconsistently to a variety of broad-spectrum antibiotic drugs, and antiepileptic, muscle relaxant, antispastic, and psychotropic drugs. The current patient's mental status improved after starting intravenous ceftriaxone but improvement of the abnormal movements occurred only after the addition of oral valproate. Current treatment consists of intravenous trimethoprim-sulfamethoxazole for 2 weeks followed by oral trimethoprim-sulfamethoxazole twice daily for 1 year. Presented here is an alternative treatment of intravenous ceftriazone followed by oral trimethoprim-sulfamethoxazole in combination with valproate for abnormal movements not responsive to antibiotic drugs alone.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7538627     DOI: 10.1002/mds.870100210

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


  8 in total

Review 1.  Whipple's disease.

Authors:  R N Ratnaike
Journal:  Postgrad Med J       Date:  2000-12       Impact factor: 2.401

2.  An unusual spinal presentation of Whipple disease.

Authors:  A Messori; P Di Bella; G Polonara; F Logullo; P Pauri; R Haghighipour; U Salvolini
Journal:  AJNR Am J Neuroradiol       Date:  2001-05       Impact factor: 3.825

3.  Slow Mandibulo-Faciolingual Wiggling Tremor Associated with Japanese Encephalitis.

Authors:  Toshiaki Takeuchi; Ryosuke Miyamoto; Yusuke Osaki; Tomohiko Takasaki; Nobuaki Yamamoto; Kenta Sato; Koji Fujita; Yuishin Izumi; Ryuji Kaji
Journal:  Mov Disord Clin Pract       Date:  2014-07-28

4.  Neurologic manifestations of Whipple's disease.

Authors:  Mara M Lugassy; Elan D Louis
Journal:  Curr Infect Dis Rep       Date:  2006-06       Impact factor: 3.725

Review 5.  Acquired pendular nystagmus.

Authors:  Sarah Kang; Aasef G Shaikh
Journal:  J Neurol Sci       Date:  2017-01-10       Impact factor: 3.181

Review 6.  Eye Movement Disorders in Movement Disorders.

Authors:  Panagiotis Kassavetis; Diego Kaski; Tim Anderson; Mark Hallett
Journal:  Mov Disord Clin Pract       Date:  2022-02-16

7.  Frequency and Characterization of Movement Disorders in Anti-IgLON5 Disease.

Authors:  Carles Gaig; Yaroslau Compta; Anna Heidbreder; Maria J Marti; Maarten J Titulaer; Yvette Crijnen; Birgit Högl; Jan Lewerenz; María Elena Erro; Juan Carlos Garcia-Monco; Pasquale Nigro; Nicola Tambasco; Maja Patalong-Ogiewa; Marcus Erdler; Stefan Macher; Evelyn Berger-Sieczkowski; Romana Höftberger; Christian Geis; Markus Hutterer; Angela Milán-Tomás; Antonio Martin-Bastida; Lydia Lopez Manzanares; Sonia Quintas; Günter U Höglinger; Nora Möhn; Florian Schoeberl; Franziska S Thaler; Gian Maria Asioli; Federica Provini; Giuseppe Plazzi; Koldo Berganzo; Morten Blaabjerg; Norbert Brüggemann; Tarsis Farias; Chen Fei Ng; Caroline Giordana; Alejandro Herrero-San Martín; Lucio Huebra; Katya Kotschet; Herburg Liendl; Teresa Montojo; Carlos Morata; Jesus Perez Perez; Inmaculada Puertas; Thomas Seifert-Held; Caspar Seitz; Mateus Mistieri Simabukuro; Nieves Tellez; Javier Villacieros-Álvarez; Barbara Willekens; Lidia Sabater; Alex Iranzo; Joan Santamaria Cano; Josep Dalmau; Francesc Graus
Journal:  Neurology       Date:  2021-08-11       Impact factor: 11.800

8.  Isolated CNS Whipple disease with normal brain MRI and false-positive CSF 14-3-3 protein: a case report and review of the literature.

Authors:  Victor W Sung; Michael J Lyerly; Kenneth B Fallon; Khurram Bashir
Journal:  Brain Behav       Date:  2012-10-01       Impact factor: 2.708

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.